Key result
Subclinical hypothyroidism was not associated with a significant difference in coronary flow reserve compared to healthy controls (2.76 vs 2.76, p=0.999).
Why the study?
Although thyroid hormones significantly affect the cardiovascular system, the impact of subtle thyroid dysfunction such as subclinical hypothyroidism remained to be determined.
Does subclinical hypothyroidism reduce coronary flow reserve in patients without known cardiovascular disease?
Cross-Sectional (n=50)
No
Does subclinical hypothyroidism reduce coronary flow reserve in patients without known cardiovascular disease?
Absolute Event Rate: 2.76% vs 2.76%
p-value: p=0.999
Subclinical hypothyroidism does not significantly impair coronary flow reserve compared to healthy controls, but it alters the sensitivity of the microvasculature to traditional cardiovascular risk factors.
May signal early microvascular dysfunction in SCH; leaves open whether levothyroxine improves CFR.
Background: Although thyroid hormones have significant effect on cardiovascular system, the impact of subtle thyroid dysfunction such as subclinical hypothyroidism (SCH) remains to be determined. We investigated coronary flow reserve (CFR) in patients with subclinical hypothyroidism. Methods: Thirty two subjects with SCH and eighteen control subjects with normal serum thyroid hormones and thyroid-stimulating hormone (TSH) levels were included in the study. TSH, free thyroxine, free triiodothyronine, glucose, insulin, HbA1c, cholesterol, triglyceride and plasma levels of C-reactive protein were measured. Coronary diastolic peak flow velocities in left anterior descending coronary artery were measured at baseline and after adenosine infusion. CFR was calculated as the ratio of hyperemic to baseline diastolic peak velocity. Results: CFR values were not significantly different between the two groups (SCH 2.76±0.35 vs controls 2.76±0.42). There was a significant correlation of CFR with waist to hip ratio, hypertension, smoking habits, markers of glucose status (glucose level, HbA1c, insulin level, HOMA IR), cholesterol, LDL-cholesterol and triglyceride levels in SCH group, whereas only cholesterol level showed significant correlation with CFR in controls. There was no correlation between CFR and thyroid hormones. Conclusions: We concluded that there is a different impact of cardiovascular risk factors on CFR in SCH patients compared to healthy control and that these two groups behave differently in the same circumstances under the same risk factors. The basis for this difference could be that the altered thyroid axis "set point" changes the sensitivity of the microvasculature in patients with SCH to known risk factors.
No takes yet. Share an insight, caveat, or question.
Stojković et al. (2021) conducted a cross-sectional in Subclinical hypothyroidism (n=50). Subclinical hypothyroidism vs. Euthyroid healthy controls was evaluated on Coronary flow reserve (CFR) (p=0.999). Subclinical hypothyroidism was not associated with a significant difference in coronary flow reserve compared to healthy controls (2.76 vs 2.76, p=0.999).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: